Literature DB >> 28986019

Pancreatic insufficiency in Cystic Fibrosis.

Vikesh K Singh1, Sarah Jane Schwarzenberg2.   

Abstract

Pancreatic insufficiency (PI) affects about 85% of the cystic fibrosis population. Although most are PI soon after birth, some will have pancreatic sufficiency (PS) for some or all of their life. Understanding the clinical presentation, diagnosis, and management of PI is crucial to the care of people with cystic fibrosis.
Copyright © 2017 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Fat soluble vitamins; Pancreas; Pancreatic enzyme therapy; Pancreatic insufficiency; Pancreatitis

Mesh:

Year:  2017        PMID: 28986019     DOI: 10.1016/j.jcf.2017.06.011

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN: 1569-1993            Impact factor:   5.482


  26 in total

1.  A high prevalence of chronic gastrointestinal symptoms in adults with cystic fibrosis is detected using tools already validated in other GI disorders.

Authors:  Bu'Hussain Hayee; Kerry-Lee Watson; Sanchika Campbell; Anna Simpson; Emma Farrell; Penelope Hutchings; Patricia Macedo; Felicity Perrin; Kevin Whelan; Caroline Elston
Journal:  United European Gastroenterol J       Date:  2019-08       Impact factor: 4.623

Review 2.  Luminal Gastrointestinal Manifestations of Cystic Fibrosis.

Authors:  Samuel J Burton; Christine Hachem; James M Abraham
Journal:  Curr Gastroenterol Rep       Date:  2021-03-23

Review 3.  The Exocrine Pancreas in Cystic Fibrosis in the Era of CFTR Modulation: A Mini Review.

Authors:  Isabelle R McKay; Chee Y Ooi
Journal:  Front Pediatr       Date:  2022-06-27       Impact factor: 3.569

Review 4.  Review of Rapid Advances in Cystic Fibrosis.

Authors:  Stephanie L Link; Ravi P Nayak
Journal:  Mo Med       Date:  2020 Nov-Dec

Review 5.  On the Corner of Models and Cure: Gene Editing in Cystic Fibrosis.

Authors:  Marjolein Ensinck; Angélique Mottais; Claire Detry; Teresinha Leal; Marianne S Carlon
Journal:  Front Pharmacol       Date:  2021-04-27       Impact factor: 5.810

Review 6.  Role of inflammation and oxidative stress in tissue damage associated with cystic fibrosis: CAPE as a future therapeutic strategy.

Authors:  Victor Emanuel Miranda Soares; Thiago Inácio Teixeira do Carmo; Fernanda Dos Anjos; Jonatha Wruck; Sarah Franco Vieira de Oliveira Maciel; Margarete Dulce Bagatini; Débora Tavares de Resende E Silva
Journal:  Mol Cell Biochem       Date:  2021-09-16       Impact factor: 3.396

7.  Use of proton pump inhibitors is associated with lower hemoglobin levels in people with cystic fibrosis.

Authors:  Alex H Gifford; Julie L Sanville; Meghana Sathe; Sonya L Heltshe; Christopher H Goss
Journal:  Pediatr Pulmonol       Date:  2021-04-26

8.  Abdominal Surgical Procedures in Adult Patients With Cystic Fibrosis: What Are the Risks?

Authors:  Melissa A Hite; Wolfgang B Gaertner; Bryan Garcia; Patrick A Flume; Pinckney J Maxwell; Virgilio V George; Thomas Curran
Journal:  Dis Colon Rectum       Date:  2022-07-05       Impact factor: 4.412

Review 9.  A tale of two pancreases: exocrine pathology and endocrine dysfunction.

Authors:  Michael R Rickels; Andrew W Norris; Rebecca L Hull
Journal:  Diabetologia       Date:  2020-09-07       Impact factor: 10.122

Review 10.  Timing of pancreatic enzyme replacement therapy (PERT) in cystic fibrosis.

Authors:  Christabella Ng; Giles Major; Alan R Smyth
Journal:  Cochrane Database Syst Rev       Date:  2021-08-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.